We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SUN:NYSESunoco LP Analysis

Data as of 2026-05-03 - not real-time

$68.35

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Sunoco LP is trading at $68.35, comfortably above its 20‑day ($65.69) and 50‑day ($64.85) simple moving averages, indicating a bullish price momentum. The RSI of 61 and a bullish MACD histogram (+0.38) further reinforce short‑term upside potential, while the 30‑day volatility of 26% suggests price swings remain pronounced. Fundamentally, the company boasts a robust 63% year‑over‑year revenue growth but operates on thin margins (gross margin ~11%) and carries an extreme debt‑to‑equity ratio of 185, raising concerns about long‑term financial resilience. Dividend yield stands out at 5.49%, yet a payout ratio exceeding 150% signals that the current distribution may not be sustainable. Overall, the stock appears overvalued relative to its industry peers (P/E 30 vs. industry 22.7) and faces medium sector and high regulatory risks, but the immediate technical setup is favorable.


Upcoming Q1 2026 earnings releases, highlighted in recent news, could act as a catalyst, especially if cash flow improves enough to support the generous dividend. Investors should weigh the attractive yield against the high leverage and modest profitability before deciding on exposure. Given the bullish technicals and upcoming earnings, a short‑term buy may be justified, but caution is warranted for longer horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMAs, bullish MACD)
  • High dividend yield attracting income investors
  • Upcoming earnings release providing potential upside catalyst

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth but thin operating margins
  • Elevated debt levels and high payout ratio
  • Valuation premium relative to industry peers

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Unsustainable dividend payout exceeding cash flow
  • Heavy debt burden limiting financial flexibility
  • Sector headwinds and heightened regulatory scrutiny

Key Metrics & Analysis

Financial Health

Revenue Growth63.20%
Profit Margin2.09%
P/E Ratio30.0
ROE8.73%
ROA2.92%
Debt/Equity185.48
P/B Ratio1.4
Op. Cash Flow$1.2B
Free Cash Flow$34.1M
Industry P/E22.7

Technical Analysis

TrendBullish
RSI61.1
Support$61.92
Resistance$70.00
MA 20$65.69
MA 50$64.85
MA 200$56.33
MACDBullish
VolumeIncreasing
Fear & Greed Index91.09

Valuation

Target Price$69.88
Upside/Downside2.23%
GradeOvervalued
TypeGrowth
Dividend Yield5.49%

Risk Assessment

Beta0.10
Volatility26.08%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.